Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$45.44 - $74.26 $16.5 Million - $27 Million
363,993 Added 518.17%
434,239 $28.5 Million
Q4 2022

Feb 14, 2023

BUY
$41.39 - $81.0 $2.23 Million - $4.37 Million
53,925 Added 330.4%
70,246 $3.16 Million
Q3 2022

Nov 14, 2022

SELL
$72.36 - $113.1 $52.7 Million - $82.3 Million
-727,962 Reduced 97.81%
16,321 $1.18 Million
Q2 2022

Aug 15, 2022

SELL
$87.2 - $114.05 $15.9 Million - $20.8 Million
-181,977 Reduced 19.65%
744,283 $79.9 Million
Q1 2022

May 16, 2022

SELL
$94.19 - $124.49 $37.1 Million - $49 Million
-393,931 Reduced 29.84%
926,260 $103 Million
Q4 2021

Feb 14, 2022

BUY
$119.57 - $139.07 $898,807 - $1.05 Million
7,517 Added 0.57%
1,320,191 $169 Million
Q3 2021

Nov 15, 2021

BUY
$109.17 - $142.35 $129 Million - $168 Million
1,181,299 Added 899.18%
1,312,674 $175 Million
Q2 2021

Aug 16, 2021

BUY
$100.34 - $115.69 $801,716 - $924,363
7,990 Added 6.48%
131,375 $14.2 Million
Q1 2021

May 17, 2021

BUY
$101.51 - $125.27 $10.9 Million - $13.5 Million
107,743 Added 688.81%
123,385 $13 Million
Q4 2020

Feb 16, 2021

SELL
$85.88 - $105.36 $1.67 Million - $2.05 Million
-19,485 Reduced 55.47%
15,642 $1.63 Million
Q3 2020

Nov 13, 2020

BUY
$72.74 - $92.5 $2.56 Million - $3.25 Million
35,127 New
35,127 $3.01 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.9B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.